These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3413730)

  • 1. Specific binding of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the intact canine platelet.
    Janero DR; Burghardt B; Burghardt C
    Thromb Res; 1988 Jun; 50(6):789-802. PubMed ID: 3413730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.
    Kloprogge E; Akkerman JW
    Biochem J; 1984 Nov; 223(3):901-9. PubMed ID: 6150705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of [3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes.
    Herbert JM; Laplace MC; Maffrand JP
    Biochem Pharmacol; 1993 Jan; 45(1):51-8. PubMed ID: 8381007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioligand competitive binding methodology for the evaluation of platelet-activating factor (PAF) and PAF-receptor antagonism using intact canine platelets.
    Janero DR; Burghardt B; Burghardt C
    J Pharmacol Methods; 1988 Nov; 20(3):237-53. PubMed ID: 2853256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
    Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
    Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes.
    Hwang SB; Lee CS; Cheah MJ; Shen TY
    Biochemistry; 1983 Sep; 22(20):4756-63. PubMed ID: 6313047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits.
    Kudolo GB; Harper MJ
    Biol Reprod; 1989 Oct; 41(4):587-603. PubMed ID: 2559778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets.
    Wade PJ; Lunt DO; Lad N; Tuffin DP; McCullagh KG
    Thromb Res; 1986 Jan; 41(2):251-62. PubMed ID: 3961730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.
    Hwang SB; Lam MH; Chang MN
    J Biol Chem; 1986 Oct; 261(29):13720-6. PubMed ID: 3020044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
    Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
    Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor binding and metabolism during human platelet aggregation.
    Valone FH
    Thromb Res; 1988 Apr; 50(1):103-12. PubMed ID: 3400077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of platelet activating factor by isolated membranes from U937 cells.
    Lee JS; Ong R; Yoo TJ; Chiang T
    Cell Immunol; 1990 Feb; 125(2):415-25. PubMed ID: 2153465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and metabolism of platelet-activating factor by human neutrophils.
    O'Flaherty JT; Surles JR; Redman J; Jacobson D; Piantadosi C; Wykle RL
    J Clin Invest; 1986 Aug; 78(2):381-8. PubMed ID: 3016027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific receptor sites for platelet activating factor on rat liver plasma membranes.
    Hwang SB
    Arch Biochem Biophys; 1987 Sep; 257(2):339-44. PubMed ID: 2821908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O; Robaut C; Cavero I
    J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
    Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
    Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.